Hunan Er Kang Pharmaceutical (300267) — Cash Flow Quality Index
Hunan Er Kang Pharmaceutical (300267) has a Cash Flow Quality Index of 6.75x as of June 2023. Operating cash flow of CN¥174.55 Million exceeds net income of CN¥25.87 Million, indicating high earnings quality where cash backs reported profits. Explore Hunan Er Kang Pharmaceutical cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hunan Er Kang Pharmaceutical Cash Flow Quality Index (2008–2022)
Historical Cash Flow Quality Index for Hunan Er Kang Pharmaceutical across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Hunan Er Kang Pharmaceutical.
Annual Cash Flow Quality Index for Hunan Er Kang Pharmaceutical (2008–2022)
Year-by-year earnings quality comparison for Hunan Er Kang Pharmaceutical.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 6.14x | CN¥281.02 Million | CN¥45.76 Million | ▲ +595.7% |
| 2020 | 0.88x | CN¥178.53 Million | CN¥202.22 Million | ▼ -68.0% |
| 2019 | 2.76x | CN¥445.82 Million | CN¥161.53 Million | ▲ +382.5% |
| 2018 | 0.57x | CN¥123.89 Million | CN¥216.58 Million | ▼ -56.6% |
| 2017 | 1.32x | CN¥689.11 Million | CN¥522.46 Million | ▲ +178.3% |
| 2016 | 0.47x | CN¥486.50 Million | CN¥1.03 Billion | ▼ -44.8% |
| 2015 | 0.86x | CN¥518.96 Million | CN¥604.58 Million | ▲ +41.1% |
| 2014 | 0.61x | CN¥175.38 Million | CN¥288.29 Million | ▼ -32.6% |
| 2013 | 0.90x | CN¥174.22 Million | CN¥192.93 Million | ▲ +63.3% |
| 2012 | 0.55x | CN¥84.02 Million | CN¥151.91 Million | ▼ -13.9% |
| 2011 | 0.64x | CN¥75.72 Million | CN¥117.81 Million | ▲ +0.6% |
| 2010 | 0.64x | CN¥42.47 Million | CN¥66.46 Million | ▲ +42.8% |
| 2009 | 0.45x | CN¥10.18 Million | CN¥22.75 Million | ▲ +2199.7% |
| 2008 | 0.02x | CN¥211.00K | CN¥10.84 Million | — |